Murry Alper brings almost 30 years of experience in the Life Sciences industry, with experience at both major manufacturers, as well as on the agency side. Murry founded Caravel Group in 2006 after a decade in marketing and sales roles at Bristol-Myers Squibb and Genentech. He has co-founded multiple medical communications agencies and was Managing Partner of Compass Group Partners upon its purchase by QHP Capital in June of 2023. He is currently Chief Commercial Markets Officer at Pro-ficiency where he leads medical communications, marketing strategy and innovation efforts.
Murry has a passion for delivering innovative solutions specific to the strategic opportunities of each client. Strengths of experience and solutions include HCP education, Thought Leader management, and marketplace & customer insights.